Interv Akut Kardiol. 2018;17(4):246-247

GLOBAL LEADERS – paving the way for better antithrombotic treatment?

Ivo Varvařovský
Kardiologické centrum Agel, Pardubice

The GLOBAL LEADERS trial failed to show superiority of short and intensive dual antiplatelet therapy followed by ticagrelor monotherapyover convention dual antiplatelet treatment after percutansous coronary angioplasty. The results of this study could layfoundations for the next research.

Keywords: ticagrelor, dual antiplatelet therapy, coronary angioplasty

Accepted: November 18, 2018; Published: December 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Varvařovský I. GLOBAL LEADERS – paving the way for better antithrombotic treatment? Interv Akut Kardiol. 2018;17(4):246-247.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Vranckx P, Valgimigli M, Jüni P. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet 2018; 392: 940-949. Go to original source... Go to PubMed...
    2. Neumann FJ, Sousa-Uva M, Ahlsonn A. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 2018; Aug 25. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.